Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Baglin

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibitionR Luddington, T Baglin
British Journal of Haematology|January 1, 1995
Altered platelet phospholipid-dependent thrombin generation in thrombocytopenia and thrombocytosisL H Lee, T Baglin
British Journal of Haematology|March 1, 1996
Effect of platelet phospholipid exposure on activated protein C resistance: implications for thrombophilia screeningR Luddington, K Brown, T Baglin
British Journal of Haematology|October 29, 1998
Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutationsK Brown, R Luddington, T Baglin
Transfusion Medicine (Oxford, England)|September 22, 2012
Cryoprecipitate: an outmoded treatment?L Yang, S Stanworth, T Baglin
British Journal of Haematology|February 15, 2002
Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleedingG Evans, R Luddington, T Baglin
Blood|August 29, 2000
Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatmentJ Taube, D Halsall, T Baglin
Thrombosis Research|December 10, 1999
Lupus anticoagulant testing with optical end point automationR Luddington, C Scales, T Baglin
British Journal of Haematology|June 20, 1998
A common polymorphism in the tumour necrosis factor-alpha gene associated with high TNF levels is not a risk factor for venous thromboembolismK Brown, R Luddington, T Baglin
Journal of Clinical Pathology|November 1, 1991
Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulationI Jennings, R J Luddington, T Baglin
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibitionR Luddington, T Baglin
British Journal of Haematology|January 1, 1995
Altered platelet phospholipid-dependent thrombin generation in thrombocytopenia and thrombocytosisL H Lee, T Baglin
British Journal of Haematology|March 1, 1996
Effect of platelet phospholipid exposure on activated protein C resistance: implications for thrombophilia screeningR Luddington, K Brown, T Baglin
British Journal of Haematology|October 29, 1998
Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutationsK Brown, R Luddington, T Baglin
Transfusion Medicine (Oxford, England)|September 22, 2012
Cryoprecipitate: an outmoded treatment?L Yang, S Stanworth, T Baglin
British Journal of Haematology|February 15, 2002
Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleedingG Evans, R Luddington, T Baglin
Blood|August 29, 2000
Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatmentJ Taube, D Halsall, T Baglin
Thrombosis Research|December 10, 1999
Lupus anticoagulant testing with optical end point automationR Luddington, C Scales, T Baglin
British Journal of Haematology|June 20, 1998
A common polymorphism in the tumour necrosis factor-alpha gene associated with high TNF levels is not a risk factor for venous thromboembolismK Brown, R Luddington, T Baglin
Journal of Clinical Pathology|November 1, 1991
Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulationI Jennings, R J Luddington, T Baglin
Pageof 8